Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
German Heroin Trial
NCT00268814Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Mar 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diamorphine in opioid use disorder (OUD) (8 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Improvement of physical state of health at 12 months, Improvement of mental state of health at 12 months and 2 more. Started Mar 2002; status: completed.
02
Drugs
diamorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00268814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268814.